or Try an Advanced Search...

    Kidney Disease Stocks List

    Symbol Grade Name % Change
    RNLX F Renalytix AI plc -15.53
    CYCN F Cyclerion Therapeutics, Inc. -7.08
    PROK C ProKidney Corp. -4.64
    CTSO F Cytosorbents Corporation -4.02
    ARDX C Ardelyx, Inc. -2.65
    CALT C Calliditas Therapeutics AB -2.27
    TRIB F Trinity Biotech plc -1.90
    UNCY D Unicycive Therapeutics, Inc. -1.89
    AKBA F Akebia Therapeutics, Inc. -1.74
    BAX F Baxter International Inc. -1.63
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Medicine Biopharmaceutical Chronic Kidney Disease Kidney Renal Disease Biotechnology Clinical Medicine Dialysis Disease End Stage Renal Disease Health Sciences Hyperphosphatemia Immune Disorders Infectious Diseases Membrane Technology Nephrology Pharmacy Phosphates Renal Dialysis Stage Renal Disease

    Related ETFs - A few ETFs which own one or more of the above listed Kidney Disease stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 10.43
    IBBQ B Invesco Nasdaq Biotechnology ETF 6.35
    MEDX D Horizon Kinetics Medical ETF 5.71
    SURE B AdvisorShares Insider Advantage ETF 5.3
    BIB C ProShares Ultra Nasdaq Biotechnology 4.37
    View all Kidney Disease ETFs...
    Compare ETFs
    Compare IBBQ to MEDX Compare MEDX to BIB Compare SURE to BIB

        Kidney Disease Stocks Recent News

        Date Stock Title
        May 21 ARDX Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
        May 21 PROK ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
        May 16 CALT In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO's Mode of Action
        May 16 ARDX Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
        May 16 CALT Invitation to the presentation of Calliditas´s interim report January - March 2024
        May 16 BAX BAXTER ANNOUNCES MISSION AND LOGO FOR PROPOSED KIDNEY CARE COMPANY VANTIVE
        May 15 RNLX Renalytix Plc (RNLX) Q3 2024 Earnings Call Transcript
        May 15 BAX Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
        May 15 CTSO CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00
        May 15 CALT Calliditas Therapeutics to Present Data at ERA 2024 May 23 - 26 in Stockholm
        May 15 CALT Notice of annual general meeting of Calliditas Therapeutics AB (publ)
        May 15 RNLX Renalytix AI GAAP EPS of -$0.08 beats by $0.01, revenue of $0.54M misses by $0.56M
        May 15 UNCY Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
        May 15 RNLX Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
        May 15 CALT Exploring Three Swedish Growth Companies With High Insider Ownership On The Swedish Exchange
        Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Chronic Kidney Disease Renal Disease Biopharmaceutical End Stage Renal Disease Phosphates Stage Renal Disease Biotechnology Cancer Dialysis Health Sciences Life Sciences Pharmacy Acid Alzheimer's Disease Asthma Chronic Obstructive Pulmonary Disease Clopidogrel Gastrointestinal Heart Failure Hemodialysis
        Kidney Disease

        Kidney disease is a condition in which the kidneys are damaged and unable to filter waste and toxins from the blood. This can lead to a buildup of waste and toxins in the body, which can cause a variety of symptoms, including fatigue, nausea, loss of appetite, and swelling in the hands and feet. In severe cases, kidney disease can lead to kidney failure, which requires dialysis or a kidney transplant.

        Browse All Tags